Skip to content
FDA Approves New Drug for Relapsing MS
Elizabeth_WebMD_Staff posted:
In a two-year study, the Aubagio reduced yearly relapses by nearly a third compared to placebo and also slowed the progression of the disease. This new med will be prescribed for relapsing forms of MS.

FDA Approves New MS Drug Aubagio

For more info about the study see this information from the National Multiple Sclerosis Society.

Will you be talking with your doctor about this?


Featuring Experts

Stephanie knows multiple sclerosis as a patient and as a nurse. Stephanie was diagnosed with multiple sclerosis in 2013. Shortly after being diagnosed...More

Helpful Tips

Hi whitefrazier - I live in OH, it took me over 2 years and 3 tries. The last try I obtained an Attorney. My age was 40-42. There is a ... More
Was this Helpful?
1 of 1 found this helpful

Related Drug Reviews

  • Drug Name User Reviews

Report Problems With Your Medications to the FDA

FDAYou are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.